Instructions for Eucaphilipt spray bottle 50 ml
Composition
active ingredient: tincture (1:10) of eucalyptus leaves (Eucalypti folium) (extractant – ethanol 96%);
1 ml of the drug contains 0.25 ml of tincture (1:10) of eucalyptus leaves (Eucalypti folium) (extractant – ethanol 96%) in terms of cineole – not less than 0.05 mg;
excipient: isopropyl myristate.
Dosage form
Spray.
Main physical and chemical properties: green to dark green liquid. A slight precipitate may form during storage.
Pharmacotherapeutic group
Means used for diseases of the throat. Antiseptics. ATX code R02A A20.
Pharmacological properties
The tincture contains tannins, ellagic acid, flavonoids, resins, wax, essential oil, which includes various terpene compounds, especially active against gram-positive and gram-negative microorganisms, which have a detrimental effect on fungi and protozoa. Eucalyptus inhibits the growth of Staphylococcus aureus, Escherichia, tuberculous mycobacteria, Trichomonas, dysentery amoeba. The main component of the essential oil is cineole monocyclic terpene. The tincture has an antiseptic, anti-inflammatory and disinfectant effect, which is due to the oxidative effect of cineole monocyclic terpene and the anti-inflammatory effect associated with almost all physiologically active substances that are part of it.
The drug exhibits antibacterial activity against staphylococci.
Indication
Inflammatory diseases of the upper respiratory tract, nasopharynx and oral cavity (tracheitis, laryngitis, pharyngitis, gingivitis, stomatitis), skin lesions (including infected wounds).
Contraindication
Bronchial asthma, bronchospasm. Individual hypersensitivity to the drug.
Inflammatory diseases of the gastrointestinal tract and biliary tract. Severe liver disease.
Interaction with other medicinal products and other types of interactions
Not installed.
Application features
Before starting use, you should consult a doctor.
Use during pregnancy or breastfeeding.
The efficacy and safety of the drug during pregnancy or breastfeeding have not been studied, so the drug should not be used in this category of patients.
The ability to influence the reaction speed when driving vehicles or other mechanisms.
When using the spray to treat diseases of the upper respiratory tract, you should refrain from driving vehicles and working with potentially dangerous mechanisms.
Method of administration and doses
Evkafilipt® should be applied topically. Before the first use, as well as if the Evkafilipt® spray has not been used for a long time (at least 1 week), press the spray pump several times, spraying the spray into the air, to obtain a uniform spray. Shake before use. For inflammation of the upper respiratory tract, nasopharynx and oral cavity (tracheitis, laryngitis, pharyngitis, gingivitis, stomatitis), adults should apply topically, spraying the drug into the oral cavity, by pressing the spray pump 3–4 times a day for 3–4 days. When treating skin lesions, moisten a gauze napkin with the drug and leave it on the skin surface or mucous membranes for 15–20 minutes. Perform the procedure 2 times a day. Apply until the therapeutic effect is achieved. The duration of treatment is determined by the doctor.
Children.
There is no experience with the use of the drug in children.
Overdose
Not installed.
Side effects
Nausea, vomiting and diarrhea. In case of hypersensitivity to the drug, allergic reactions may occur (urticaria, redness and rashes on the skin, itching, Quincke's edema), sometimes - contact dermatitis (in the lip area). In case of severe reactions, the use of the drug should be discontinued.
Reporting adverse reactions after the registration of a medicinal product is important. This allows monitoring of the benefit/risk ratio when using this medicinal product. Medical and pharmaceutical professionals, as well as patients or their legal representatives, should report all cases of suspected adverse reactions and lack of efficacy of the medicinal product via the Automated Information System for Pharmacovigilance at the link: https://aisf.dec.gov.ua.
Expiration date
2 years.
Do not use after the expiry date stated on the packaging.
Storage conditions
Store in the original packaging at a temperature not exceeding 25 °C.
Keep out of reach of children.
Packaging
20 ml in a glass bottle with a spray pump and a rotating nozzle or 50 ml in a glass bottle with a spray pump and a neck nozzle.
Vacation category
Without a prescription.
Producer
PJSC "Chempharmaceutical Plant "Chervona Zirka".
Location of the manufacturer and address of its place of business.
61010, Ukraine, Kharkiv, 1 Hordienkivska St.
